Association between cognitive performance and self-reported glaucoma in middle-aged and older adults: a cross-sectional analysis of ELSA-Brasil

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRAS DIVULG CIENTIFICA
Autores
VIDAL, K. S.
MORENO, A. B.
DUNCAN, B.
I, M. Schmidt
MAESTRI, M.
BARRETO, S. M.
Citação
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, v.53, n.12, article ID e10347, 8p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Recent evidence suggests that glaucoma and Alzheimer's disease are neurodegenerative diseases sharing common pathophysiological and etiological features, although findings are inconclusive. We sought to investigate whether self-reported glaucoma patients without dementia present poorer cognitive performance, an issue that has been less investigated. We employed cross-sectional data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) and included participants >= 50 years of age without a known diagnosis of dementia and a self-reported glaucoma diagnosis. We excluded those with previous stroke, other eye conditions, and using drugs that could impair cognition. We evaluated cognition using delayed word recall, phonemic verbal fluency, and trail making (version B) tests. We used multinomial linear regression models to investigate associations between self-reported glaucoma with cognition, adjusted by several sociodemographic and clinical variables. Out of 4,331 participants, 139 reported glaucoma. Fully-adjusted models showed that self-reported glaucoma patients presented poorer performance in the verbal fluency test beta=-0.39, 95%CI=-0.64 to -0.14, P=0.002), but not in the other cognitive assessments. Thus, our results support the hypothesis that self-reported glaucoma is associated with poor cognitive performance; however, longitudinal data are necessary to corroborate our findings.
Palavras-chave
Cohort study, Cognitive performance, Glaucoma, Retinal diseases, Elderly
Referências
  1. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  2. Ascaso FJ, 2014, J NEUROL, V261, P1522, DOI 10.1007/s00415-014-7374-z
  3. Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078
  4. Bertolucci PHF, 2001, ARQ NEURO-PSIQUIAT, V59, P532, DOI 10.1590/S0004-282X2001000400009
  5. Brunoni AR, 2020, J AFFECT DISORDERS, V263, P252, DOI 10.1016/j.jad.2019.11.155
  6. Bulut M, 2016, ARQ BRAS OFTALMOL, V79, P100, DOI 10.5935/0004-2749.20160030
  7. Chor D, 2013, REV SAUDE PUBL, V47, P27, DOI 10.1590/S0034-8910.2013047003835
  8. Chung SD, 2015, EYE, V29, P1340, DOI 10.1038/eye.2015.120
  9. Clark LJ, 2009, AM J ALZHEIMERS DIS, V24, P461, DOI 10.1177/1533317509345154
  10. Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
  11. Passos VMD, 2014, SAO PAULO MED J, V132, P170, DOI 10.1590/1516-3180.2014.1323646
  12. Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238
  13. Garcia-Martin ES, 2014, OPHTHALMOLOGY, V121, P1149, DOI 10.1016/j.ophtha.2013.12.023
  14. GREENLIEF CL, 1985, PERCEPT MOTOR SKILL, V61, P1283, DOI 10.2466/pms.1985.61.3f.1283
  15. HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804
  16. Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P1429, DOI 10.1001/jama.2018.1536
  17. Jefferis JM, 2013, OPHTHAL EPIDEMIOL, V20, P82, DOI 10.3109/09286586.2012.757626
  18. Lee SSY, 2020, OPHTHAL PHYSL OPT, V40, P333, DOI 10.1111/opo.12679
  19. LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415
  20. McCoskey Makayla, 2018, Neurodegener Dis, V18, P315, DOI 10.1159/000496233
  21. MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457
  22. Nunes M. A., 2011, REV HCPA, V31, P487
  23. Piccinelli M, 1997, BRIT MED J, V314, P420, DOI 10.1136/bmj.314.7078.420
  24. Qu XX, 2019, BRAIN RES, V1718, P83, DOI 10.1016/j.brainres.2019.05.006
  25. SADUN AA, 1990, OPHTHALMOLOGY, V97, P9
  26. Schmidt MI, 2013, REV SAUDE PUBL, V47, P105, DOI 10.1590/S0034-8910.2013047003889
  27. Sen S, 2020, EYE, V34, P1546, DOI 10.1038/s41433-020-0836-x
  28. Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772
  29. Su CW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002833
  30. Valenti Denise A, 2011, Int J Alzheimers Dis, V2010, P793931, DOI 10.4061/2010/793931
  31. van Koolwijk LME, 2009, INVEST OPHTH VIS SCI, V50, P4576, DOI 10.1167/iovs.08-3181
  32. Varin M, 2020, OPHTHALMOLOGY, V127, P660, DOI 10.1016/j.ophtha.2019.10.004
  33. Varma R, 2011, AM J OPHTHALMOL, V152, P515, DOI 10.1016/j.ajo.2011.06.004